Filtered By:
Source: Atherosclerosis
Condition: Heart Failure

This page shows you your search results in order of relevance. This is page number 5.

Order by Relevance | Date

Total 212 results found since Jan 2013.

Angiotensin Receptor-Neprilysin Inhibitor Effects on Atherosclerotic Cardiovascular Disease Events: A Meta-Analysis of Randomized Controlled Trials
In conclusion, this meta-analysis found no association between ARNI therapy and improved ASCVD events in patients with HF.PMID:37619492 | DOI:10.1016/j.amjcard.2023.07.154
Source: Atherosclerosis - August 24, 2023 Category: Cardiology Authors: Lis Victoria Ravani Douglas Mesadri Gewehr Pedro Calomeni Mateus de Miranda Gauza Jussara Pereira Rhanderson Cardoso Henrique Barbosa Ribeiro Edimar Bocchi Source Type: research

8-hydroxy-2'-deoxyguanosine and cardiovascular disease: a systematic review.
In conclusion, high levels of 8-OHdG in blood and urine are associated with atherosclerosis and heart failure, but further large prospective studies are needed to investigate 8-OHdG as a predictor for cardiovascular diseases. PMID: 25252787 [PubMed - in process]
Source: Atherosclerosis - September 29, 2014 Category: Cardiology Authors: Kroese LJ, Scheffer PG Tags: Curr Atheroscler Rep Source Type: research

Long-term cardiovascular complications following sepsis: is senescence the missing link?
Ann Intensive Care. 2021 Dec 1;11(1):166. doi: 10.1186/s13613-021-00937-y.ABSTRACTAmong the long-term consequences of sepsis (also termed "post-sepsis syndrome") the increased risk of unexplained cardiovascular complications, such as myocardial infarction, acute heart failure or stroke, is one of the emerging specific health concerns. The vascular accelerated ageing also named premature senescence is a potential mechanism contributing to atherothrombosis, consequently leading to cardiovascular events. Indeed, vascular senescence-associated major adverse cardiovascular events (MACE) are a potential feature in sepsis survivo...
Source: Atherosclerosis - December 1, 2021 Category: Cardiology Authors: Hamid Merdji Val érie Schini-Kerth Ferhat Meziani Florence Toti Source Type: research

Promising Nutritional Fruits Against Cardiovascular Diseases: An Overview of Experimental Evidence and Understanding Their Mechanisms of Action
Vasc Health Risk Manag. 2021 Nov 23;17:739-769. doi: 10.2147/VHRM.S328096. eCollection 2021.ABSTRACTCardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality in both developed and developing countries, affecting millions of individuals each year. Despite the fact that successful therapeutic drugs for the management and treatment of CVDs are available on the market, nutritional fruits appear to offer the greatest benefits to the heart and have been proved to alleviate CVDs. Experimental studies have also demonstrated that nutritional fruits have potential protective effects against CVDs. The ai...
Source: Atherosclerosis - December 3, 2021 Category: Cardiology Authors: Nur Zulaikha Azwa Zuraini Mahendran Sekar Yuan Seng Wu Siew Hua Gan Srinivasa Reddy Bonam Nur Najihah Izzati Mat Rani M Yasmin Begum Pei Teng Lum Vetriselvan Subramaniyan Neeraj Kumar Fuloria Shivkanya Fuloria Source Type: research

Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial
CONCLUSION: The addition of colchicine to standard medical therapy in ACS patients significantly reduces MACE occurrence and improves survival rate over the time.PMID:34876021 | DOI:10.1186/s12872-021-02393-9
Source: Atherosclerosis - December 8, 2021 Category: Cardiology Authors: Mehdi Akrami Peyman Izadpanah Mehdi Bazrafshan Unes Hatamipour Navid Nouraein Hamed Bazrafshan Drissi Alireza Manafi Source Type: research

Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
Conclusions Consideration of heterogeneity and longitudinal changes in obesity measures is needed in clinical care for a more precision-oriented view of CVD risk.PMID:34889111 | DOI:10.1161/JAHA.121.019946
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Laura M Raffield Annie Green Howard Misa Graff Dan-Yu Lin Susan Cheng Ellen Demerath Chiadi Ndumele Priya Palta Casey M Rebholz Sara Seidelmann Bing Yu Penny Gordon-Larsen Kari E North Christy L Avery Source Type: research

Medicinal Plants in the Treatment of Hypertension: A Review
Adv Pharm Bull. 2021 Sep;11(4):601-617. doi: 10.34172/apb.2021.090. Epub 2020 Nov 1.ABSTRACTTraditional medicine is a comprehensive term for ancient, culture-bound health care practices that existed before the use of science in health matters and has been used for centuries. Medicinal plants are used to treat patients with cardiovascular diseases, which may occur due to ailments of the heart and blood vessels and comprise heart attacks, cerebrovascular diseases, hypertension, and heart failure. Hypertension causes difficulty in the functioning of the heart and is involved in atherosclerosis, raising the risk of heart attac...
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Raha Kamyab Hossein Namdar Mohammadali Torbati Morteza Ghojazadeh Mostafa Araj-Khodaei Seyyed Mohammad Bagher Fazljou Source Type: research

Obesity Duration, Severity, and Distribution Trajectories and Cardiovascular Disease Risk in the Atherosclerosis Risk in Communities Study
Conclusions Consideration of heterogeneity and longitudinal changes in obesity measures is needed in clinical care for a more precision-oriented view of CVD risk.PMID:34889111 | DOI:10.1161/JAHA.121.019946
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Laura M Raffield Annie Green Howard Misa Graff Dan-Yu Lin Susan Cheng Ellen Demerath Chiadi Ndumele Priya Palta Casey M Rebholz Sara Seidelmann Bing Yu Penny Gordon-Larsen Kari E North Christy L Avery Source Type: research

Medicinal Plants in the Treatment of Hypertension: A Review
Adv Pharm Bull. 2021 Sep;11(4):601-617. doi: 10.34172/apb.2021.090. Epub 2020 Nov 1.ABSTRACTTraditional medicine is a comprehensive term for ancient, culture-bound health care practices that existed before the use of science in health matters and has been used for centuries. Medicinal plants are used to treat patients with cardiovascular diseases, which may occur due to ailments of the heart and blood vessels and comprise heart attacks, cerebrovascular diseases, hypertension, and heart failure. Hypertension causes difficulty in the functioning of the heart and is involved in atherosclerosis, raising the risk of heart attac...
Source: Atherosclerosis - December 10, 2021 Category: Cardiology Authors: Raha Kamyab Hossein Namdar Mohammadali Torbati Morteza Ghojazadeh Mostafa Araj-Khodaei Seyyed Mohammad Bagher Fazljou Source Type: research

MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
Front Cell Dev Biol. 2021 Dec 2;9:799049. doi: 10.3389/fcell.2021.799049. eCollection 2021.ABSTRACTCardiovascular and cerebrovascular diseases are a serious threaten to the health of modern people. Understanding the mechanism of occurrence and development of cardiovascular and cerebrovascular diseases, as well as reasonable prevention and treatment of them, is a huge challenge that we are currently facing. The miR-125 family consists of hsa-miR-125a, hsa-miR-125b-1 and hsa-miR-125b-2. It is a kind of miRNA family that is highly conserved among different species. A large amount of literature shows that the lack of miR-125 c...
Source: Atherosclerosis - December 20, 2021 Category: Cardiology Authors: Yang Wang Jing Tan Lu Wang Gaiqin Pei Hongxin Cheng Qing Zhang Shiqi Wang Chengqi He Chenying Fu Quan Wei Source Type: research

Clinical Outcomes of Acute Myocardial Infarction Hospitalizations with Systemic Lupus Erythematosus: An Analysis of Nationwide Readmissions Database
CONCLUSION: Patients with AMI and SLE had higher inpatient mortality during the index hospitalization and higher 30-day hospital readmissions compared to AMI patients without SLE. There were no significant differences in most of the other major inpatient outcomes between the two cohorts.PMID:34936910 | DOI:10.1016/j.cpcardiol.2021.101086
Source: Atherosclerosis - December 22, 2021 Category: Cardiology Authors: Shazib Sagheer Pallav Deka Dola Pathak Umair Khan Syeda Humna Zaidi Anum Akhlaq James Blankenship Ann Annis Source Type: research

Effects of Puerarin on the Prevention and Treatment of Cardiovascular Diseases
Front Pharmacol. 2021 Dec 7;12:771793. doi: 10.3389/fphar.2021.771793. eCollection 2021.ABSTRACTPuerarin, an isoflavone glycoside derived from Pueraria lobata (Willd.) Ohwi, has been identified as a pharmacologically active component with diverse benefits. A large number of experimental and clinical studies have demonstrated that puerarin is widely used in the treatment of a variety of diseases. Among them, cardiovascular diseases (CVDs) are the leading cause of death in the world, and therefore remain one of the most prominent global public health concerns. In this review, we systematically analyze the preclinical investi...
Source: Atherosclerosis - December 24, 2021 Category: Cardiology Authors: Yan-Xi Zhou Hong Zhang Cheng Peng Source Type: research